iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.190
-0.010 (-0.83%)
At close: Sep 15, 2026, 4:00 PM EDT
1.220
+0.030 (2.52%)
After-hours: Sep 15, 2026, 4:13 PM EDT
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $76.53 million as of September 15, 2026. Its market cap has increased by 317.09% in one year.
Market Cap
76.53M
Enterprise Value
-9.32M
1-Year Change
317.09%
Ranking
Category
Stock Price
$1.19
ChartMarket Cap Chart
Since August 19, 2008, iBio, Inc.'s market cap has increased from $14.01M to $76.53M, an increase of 446.12%. That is a compound annual growth rate of 9.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 76.53M | 76.32% |
| Dec 31, 2025 | 43.40M | 93.61% |
| Dec 31, 2024 | 22.42M | 716.05% |
| Dec 29, 2023 | 2.75M | -41.32% |
| Dec 30, 2022 | 4.68M | -96.09% |
| Dec 31, 2021 | 119.66M | -46.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 80.84M |
| Telomir Pharmaceuticals | 80.47M |
| Kalaris Therapeutics | 80.46M |
| RenovoRx | 79.43M |
| MAIA Biotechnology | 79.07M |
| OS Therapies | 77.49M |
| BioStem Technologies | 76.93M |
| Gain Therapeutics | 76.38M |